DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vyvanse (Lisdexamfetamine Dimesylate) - Current Clinical Trials

 
 



Vyvanse Related Clinical Trials

Effect of Vyvanse on Driving in Young Adults With ADHD [Completed]

Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD) [Completed]

Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity [Terminated]

Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression [Terminated]

Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults [Completed]

Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence [Completed]

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD) [Completed]

Lisdexamfetamine's Effect In ADHD in the Brain and Cognition [Recruiting]

A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers [Completed]

Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation [Recruiting]

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder [Completed]

LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women [Completed]

Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis [Completed]

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder [Completed]

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder [Completed]

Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. [Recruiting]

Attention & Memory Impairments in Menopausal Women [Completed]

Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence [Recruiting]

Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity [Recruiting]

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD [Completed]

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression [Terminated]

NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD [Completed]

Treatment of Cocaine Dependence With Lisdexamfetamine [Completed]

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Completed]

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate [Completed]

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study [Completed]

Effectiveness and Duration of Effect of Open Treatment in Adult Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate- LDX (Vyvanse) [Completed]

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories [Completed]

Effects of LDX on Functioning of College Students With ADHD [Completed]

Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation [Recruiting]

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome [Completed]

Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study [Completed]

Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD [Completed]

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 [Completed]

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits [Completed]

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse [Completed]

Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD [Recruiting]

An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Completed]

Sequencing Treatments for Mothers With ADHD and Their At - Risk Children [Recruiting]

Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Completed]

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression [Terminated]

Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder [Completed]

Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) [Completed]

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) [Completed]

Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence [Recruiting]

Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder [Completed]

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17 [Completed]

Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? [Completed]

Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Completed]

Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers [Completed]

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder [Completed]

E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy [Completed]

Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder [Completed]

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms [Completed]

Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers [Completed]

LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy [Recruiting]

Open Label Extension in Adults With Binge Eating Disorder (BED) [Completed]

SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Completed]

SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Completed]

A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users [Completed]

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) [Completed]

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder [Completed]

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder [Completed]

ADHD Medication and Predictors of Treatment Outcome [Not yet recruiting]

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss [Completed]

Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) [Recruiting]

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia [Terminated]

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia [Withdrawn]

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia [Terminated]

Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Completed]

Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder [Recruiting]

Omega-3 Supplementation to ADHD Medication in Children [Recruiting]

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits [Recruiting]

Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Completed]

The Reinforcing Mechanisms of Smoking in Adult ADHD [Completed]

Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) [Withdrawn]

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia [Terminated]

Event Rate and Effects of Stimulants in ADHD [Not yet recruiting]

Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder [Not yet recruiting]

Efficacy of Intuniv Extended Release as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015